Enanta Pharmaceuticals, Inc. (ENTA) financial statements (2022 and earlier)

Company profile

Business Address 500 ARSENAL STREET
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments259,052244,002386,649335,236308,730223,669210,084
Cash and cash equivalents99,06857,20687,13151,23063,90265,67516,577
Short-term investments159,984186,796299,518284,006244,828157,994193,507
Receivables27,64823,57623,49251,31367,20510,61412,841
Other undisclosed current assets40,25751,44326,69615,2994,4543,5369,231
Total current assets:326,957319,021436,837401,848380,389237,819232,156
Noncurrent Assets
Operating lease, right-of-use asset18,8344,7117,020 
Property, plant and equipment5,4355,9438,59610,9278,3748,0498,004
Long-term investments and receivables88,668108,41632,63465,01316,38970,03832,119
Long-term investments88,668108,41632,63465,01316,38970,03832,119
Restricted cash and investments608608608608608608608
Deferred income tax assets  345 
Other noncurrent assets9292929292  
Deferred tax assets, net8,37510,1238,390
Other undisclosed noncurrent assets   11,341   
Total noncurrent assets:113,637119,77049,29587,98133,83888,81849,121
TOTAL ASSETS:440,594438,791486,132489,829414,227326,637281,277
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34,42131,96919,89622,60916,02520,9827,889
Accounts payable7,8419,5405,7376,6894,7453,7143,377
Accrued liabilities26,58022,42914,15915,9209,8927,9704,512
Taxes payable    1,3889,298 
Other undisclosed current liabilities3,4694,2034,261    
Total current liabilities:37,89036,17224,15722,60916,02520,9827,889
Noncurrent Liabilities
Long-term debt and lease obligation15,9581,1263,838    
Operating lease, liability15,9581,1263,838 
Liabilities, other than long-term debt8565581,0783,1002,8952,4102,042
Other liabilities8565581,0783,1002,8952,4102,042
Other undisclosed noncurrent liabilities1,5061,5061,4791,6281,6281,5691,410
Total noncurrent liabilities:18,3203,1906,3954,7284,5233,9793,452
Total liabilities:56,21039,36230,55227,33720,54824,96111,341
Stockholders' equity
Stockholders' equity attributable to parent384,384399,429455,580462,492393,679301,676269,936
Common stock205202201197194191190
Additional paid in capital366,724351,033326,963298,409276,526256,241242,081
Accumulated other comprehensive income (loss)(1,006)(382)844146(398)(112)19
Retained earnings18,46148,576127,572163,740117,35745,35627,646
Total stockholders' equity:384,384399,429455,580462,492393,679301,676269,936
TOTAL LIABILITIES AND EQUITY:440,594438,791486,132489,829414,227326,637281,277

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Revenues92,97997,074122,473205,197206,625102,81488,268
Revenue, net37,81458,268
Gross profit:92,97997,074122,473205,197206,625102,81488,268
Operating expenses(220,662)(206,647)(164,112)(168,459)(118,297)(78,200)(57,427)
Operating income (loss):(127,683)(109,573)(41,639)36,73888,32824,61430,841
Nonoperating income1,5751,9946,6208,8194,7932,3331,719
Investment income, nonoperating (27)149 (59)2,3731,764
Other nonoperating income1,242      
Interest and debt expense     (40)(45)
Income (loss) from continuing operations before equity method investments, income taxes:(126,108)(107,579)(35,019)45,55793,12126,90732,515
Other undisclosed income from continuing operations before income taxes     4045
Income (loss) from continuing operations before income taxes:(126,108)(107,579)(35,019)45,55793,12126,94732,560
Income tax expense (benefit)25,32528,583(1,149)826(21,165)(9,237)(10,894)
Net income (loss) available to common stockholders, diluted:(100,783)(78,996)(36,168)46,38371,95617,71021,666

Comprehensive Income ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Net income (loss):(100,783)(78,996)(36,168)46,38371,95617,71021,666
Other comprehensive loss    (286)(131)(14)
Comprehensive income (loss):(100,783)(78,996)(36,168)46,38371,67017,57921,652
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,411)(1,226)698544   
Comprehensive income (loss), net of tax, attributable to parent:(102,194)(80,222)(35,470)46,92771,67017,57921,652

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: